Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Icec0942
2. Ct7001
3. Icec-0942
4. 1805833-75-3
5. Icec0942 Free Base
6. Ct-7001
7. 46d4hs9oda
8. 1805833-75-3 (free Base)
9. Samuraciclib Hcl
10. (3~{r},4~{r})-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol
11. (3r,4r)-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol
12. 3-piperidinol, 4-(((3-(1-methylethyl)-7-((phenylmethyl)amino)pyrazolo(1,5-a)pyrimidin-5-yl)amino)methyl)-, (3r,4r)-
13. (3r,4r)-4-[[[7-[(phenylmethyl)amino]-3-propan-2-yl-pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol
14. 3-piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3r,4r)-
15. Samuraciclib Di-hcl
16. Ct7001 Di-hcl
17. Samuraciclib [inn]
18. Unii-46d4hs9oda
19. Ct-7001 Di-hcl
20. Ct7001 Hcl
21. Samuraciclib [who-dd]
22. Ct-7001 Hcl
23. Gtpl9903
24. Ppda-001
25. Chembl4297488
26. Schembl17032274
27. Ex-a3445
28. Bdbm50526797
29. Mfcd32638713
30. Nsc832261
31. Nsc835588
32. Nsc-832261
33. Nsc-835588
34. Hy-103712
35. (3r,4r)-4-(((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)methyl)piperidin-3-ol
36. (3r,4r)-4-((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-ylamino)methyl)piperidin-3-ol Dihydrochloride
37. (3r,4r)-4-({[7-(benzylamino)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-5-yl]amino}methyl)piperidin-3-ol
38. 3-piperidinol,4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-,(3r,4r)-
| Molecular Weight | 394.5 g/mol |
|---|---|
| Molecular Formula | C22H30N6O |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 394.24810960 g/mol |
| Monoisotopic Mass | 394.24810960 g/mol |
| Topological Polar Surface Area | 86.5 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 500 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Samuraciclib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Samuraciclib, including repackagers and relabelers. The FDA regulates Samuraciclib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Samuraciclib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Samuraciclib supplier is an individual or a company that provides Samuraciclib active pharmaceutical ingredient (API) or Samuraciclib finished formulations upon request. The Samuraciclib suppliers may include Samuraciclib API manufacturers, exporters, distributors and traders.
Samuraciclib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Samuraciclib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Samuraciclib GMP manufacturer or Samuraciclib GMP API supplier for your needs.
A Samuraciclib CoA (Certificate of Analysis) is a formal document that attests to Samuraciclib's compliance with Samuraciclib specifications and serves as a tool for batch-level quality control.
Samuraciclib CoA mostly includes findings from lab analyses of a specific batch. For each Samuraciclib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Samuraciclib may be tested according to a variety of international standards, such as European Pharmacopoeia (Samuraciclib EP), Samuraciclib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Samuraciclib USP).
LOOKING FOR A SUPPLIER?
